Pneumonia: Vaccination

(asked on 15th June 2018) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 6 June 2018 to Question 148810 on Pneumonia: Vaccination, if he will place in the Library the estimates reviewed by the Joint Committee on Vaccination, on the effect of the change in the infant vaccination schedule of the incidence of (a) invasive pneumococcal disease and (b) non-invasive pneumococcal disease.


Answered by
Steve Brine Portrait
Steve Brine
This question was answered on 20th June 2018

Public Health England has undertaken modelling on the impact of a reduced dose pneumococcal conjugate vaccine schedule on invasive pneumococcal disease in the United Kingdom. The Joint Committee on Vaccination and Immunisation (JCVI) has considered the relative impact on non-invasive disease.

As the JCVI is reviewing the pneumococcal programme, the estimates requested are not yet finalised. The modelling will be submitted for publication in a peer reviewed journal in 2018. The minutes of the JCVI pneumococcal sub-committee and the JCVI meetings, held on 10 May and 6 June respectively, will be published on or before 18 July 2018.

The JCVI keeps all immunisation programmes under review. The JCVI is undertaking a full review of the pneumococcal programme, and will review their advice on childhood, adult and risk group vaccination.

Reticulating Splines